CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia

Abstract

CCCDTD5 deprescribing recommendations provide evidence-informed recommendations related to cognitive enhancer deprescribing that will facilitate shared decision making among patients, care partners, and clinicians.